Regular exercise 'may delay Alzheimer's progression'
15 Jul 2008

Patients diagnosed with early stage Alzheimer's disease may benefit from regular exercise and physical activity, research suggests.

A study published by the American Academy of Neurology found that mild Alzheimer's patients may be able to preserve cognitive function for longer by maintaining a higher level of physical fitness.

The study, involved 121 participants aged 60 and above, and is the first of its kind to investigate the association between cardiorespiratory fitness and Alzheimer's disease in older patients.

Researcher Dr Jeffrey M Burns, of the University of Kansas School of Medicine in Kansas City, explained: "People with early Alzheimer's disease who were less physically fit had four times more brain shrinkage when compared to normal older adults than those who were more physically fit, suggesting less brain shrinkage related to the Alzheimer's disease process in those with higher fitness levels."

According to Dr Burns, evidence indicates that a decrease in brain volume can be linked to a decline cognitive function.

Alzheimer Europe states that between 50 and 70 per cent of all people diagnosed with dementia are suffering from Alzheimer's disease.

Login and visit the Alzheimer's Disease Knowledge Centre

Print Article    Bookmark

• Blood sugar warning for the prevention of Alzheimer's 30/12/08
• Brain starvation seems to trigger Alzheimer's, study suggests 29/12/08
• Plans for new Alzheimer's clinics unveiled 24/12/08
• Cardiovascular proteins found to work together to speed up Alzheimer's 22/12/08
• Research looks at strategy games in the prevention of cognitive deterioration 12/12/08

• EBIXA 10mg film-coated tablets - 50.88%
  Treatment of patients with moderately severe to severe Alzheimers disease ...
  
  
• CERETEC - 26.56%
  ... the diagnosis of abnormalities of regional cerebral blood flow, such as those occurring following stroke and other cerebrovascular disease, epilepsy, Alzheimer's Disease and other forms of dementia, transient ischaemic attack, migraine and tumours of the brain. (ii) Technetium [99mTc] Exametazime ...
  
  
• EBIXA 10 mg/g oral drops, solution - 25.26%
  Treatment of patients with moderate to severe Alzheimer's disease ...
  
  
• EXELON Capsules - 25.26%
  Symptomatic treatment of mild to moderately severe Alzheimer's dementia. Symptomatic treatment of mild to moderately severe dementia in patients with idiopathic Parkinson's disease ...
  
  
• CEREZYME 400 U Solution for Infusion - 25.04%
  ... disease and who exhibit clinically significant non-neurological manifestations of the disease. The non-neurological manifestations of Gaucher disease include one or more of the following conditions: • anaemia after exclusion of other causes, such as iron deficiency • thrombocytopenia • bone disease ...
  
  
• CEREZYME 200 U Solution for Infusion - 25.04%
  ... disease and who exhibit clinically significant non-neurological manifestations of the disease. The non-neurological manifestations of Gaucher disease include one or more of the following conditions: • anaemia after exclusion of other causes, such as iron deficiency • thrombocytopenia • bone disease ...